Engineering an Anti-Cd52 Antibody for Enhanced Deamidation Stability

mAbs - United States
doi 10.1080/19420862.2019.1631117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice

International Journal of Cancer
Cancer ResearchOncology
2008English

Stabilizing the CH2 Domain of an Antibody by Engineering in an Enhanced Aromatic Sequon

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2016English

Stability Engineering of Antibody Single-Chain Fv Fragments

Journal of Molecular Biology
Structural BiologyMolecular BiologyBiophysics
2001English

Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Microglial Internalization and Degradation of Pathological Tau Is Enhanced by an Anti-Tau Monoclonal Antibody

Scientific Reports
Multidisciplinary
2015English

Differential Reconstitution of T Cell Subsets Following Immunodepleting Treatment With Alemtuzumab (Anti-Cd52 Monoclonal Antibody) in Patients With Relapsing-Remitting Multiple Sclerosis

Journal of Immunology
AllergyImmunology
2013English

Bridges to Stability: Engineering Disulfide Bonds Towards Enhanced Lipase Biodiesel Synthesis

ChemCatChem
Organic ChemistryInorganic ChemistryCatalysisTheoretical ChemistryPhysical
2019English

An Anti-Cd133 Monoclonal Antibody CMab-43 Exerts Anti-Tumor and Anti-Metastasis Activities for Colon Cancers

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Anti-Myostatin Antibody Therapy for Myopathies

Clinical Neurology
Neurology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy